WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009133442) AZABICYCLIC COMPOUNDS, PREPARATION THEREOF AND USE OF SAME AS DRUGS, ESPECIALLY BETA-LACTAMASE INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/133442    International Application No.:    PCT/IB2009/005391
Publication Date: 05.11.2009 International Filing Date: 24.04.2009
IPC:
C07D 471/08 (2006.01), A61K 31/439 (2006.01), A61P 31/04 (2006.01)
Applicants: NOVEXEL [FR/FR]; 102 Avenue Gaston Roussel F-93230 Romainville (FR) (For All Designated States Except US).
LEDOUSSAL, Benoît [FR/FR]; (FR) (For US Only).
GOURDEL, Marie-Edith [FR/FR]; (FR) (For US Only)
Inventors: LEDOUSSAL, Benoît; (FR).
GOURDEL, Marie-Edith; (FR)
Agent: POCHART, François; Cabinet Hirsch-Pochart & Associes 58, Avenue Marceau F-75008 Paris (FR)
Priority Data:
08/02395 29.04.2008 FR
Title (EN) AZABICYCLIC COMPOUNDS, PREPARATION THEREOF AND USE OF SAME AS DRUGS, ESPECIALLY BETA-LACTAMASE INHIBITORS
(FR) COMPOSES AZABIYCLIQUES, LEUR PREPARATION ET LEUR UTILISATION COMME MEDICAMENTS, NOTAMMENT INHIBITEURS DE BETA-LACTAMASE
Abstract: front page image
(EN)The invention relates to compounds corresponding to the formula (I): in which R1 and R2 represent one a hydrogen and the other a fluorine or both a fluorine, in free form, in the form of zwitterions and of salts with pharmaceutically acceptable mineral or organic bases, preparation thereof and use of same as medicinal products that inhibit the action of β-lactamases by pathogenic bacteria.
(FR)L ' invention concerne les composés répondant à la formule ( I ) : dans laquelle R1 et R2 représentent l'un un hydrogène et l'autre un fluor ou tous les deux un fluor, sous forme libre, de zwitterions et de sels avec les bases minérales ou organiques pharmaceutiquement acceptables, leur préparation et leur utilisation comme médicaments inhibiteurs de l'action des β- lactamases par les bactéries pathogènes.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: French (FR)
Filing Language: French (FR)